Novo Nordisk AS NVO and Hims & Hers Health Inc. HIMS have reportedly ended their public feud, with the drugmaker deciding to ...

March 6 () - Wegovy maker Novo ‌Nordisk plans to ‌sell its weight-loss drugs ​on Hims & Hers Health platform, bringing an end ...

Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.

Market analysts have expressed surprise at the move, as ​both Novo and Hims have been previously engaged in legal battle over ...

Novo Nordisk has sued Hims & Hers for patent infringement, saying the online site is selling cheaper, unapproved copies of the Wegovy weight loss drug ...

Novo's lawsuit comes less than one week after Hims & Hers announced plans to sell a compounded version of Novo's weight-loss pill Wegovy.

Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy.

Pharmaceutical giant Novo Nordisk announced Monday it is suing telemedicine platform Hims & Hers for allegedly “deceiving patients and putting their health at risk” by selling compounded versions of ...

Novo Nordisk (NVO) stock is in focus as Strive Pharmacy, a pharmacy partner for Hims & Hers (HIMS) plans to offer a compounded version of Wegovy pill. Read more here.

Add Yahoo as a preferred source to see more of our stories on Google. Novo Nordisk files suit against telehealth provider Hims & Hers, alleging unauthorized versions of Ozempic and Wegovy. The case ...

Novo Nordisk is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker's new Wegovy obesity pill and injections in the U.S. Novo is asking the ...